Tenormin and Afinitor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tenormin (atenolol) and Afinitor (everolimus). Common drug interactions include pulmonary oedema among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Tenormin and Afinitor. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Tenormin?

Tenormin has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 20,474 Tenormin users. Check the latest studies of Tenormin.

What is Afinitor?

Afinitor has active ingredients of everolimus. It is often used in breast cancer metastatic. eHealthMe is studying from 41,680 Afinitor users. Check the latest studies of Afinitor.

On Jul, 26, 2026

49 people who take Tenormin and Afinitor together, and have interactions are studied.

Tenormin and Afinitor drug interactions.

What are the common drug interactions of Tenormin and Afinitor, by gender? *:

female:

Pulmonary oedema (fluid accumulation in the lungs)
Malignant neoplasm progression (cancer tumour came back)
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Skin disorder (skin disease)
Neoplasm progression (growth of tumour)
Platelet count decreased
Coagulopathy (blood's ability to clot is impaired)
Dizziness
Failure to thrive (inadequate weight gain and physical growth in children)
Fluid retention (an abnormal accumulation of fluid in the blood)

male:

Pyrexia (fever)
Renal impairment (severely reduced kidney function)
Nausea (feeling of having an urge to vomit)
Anaemia (lack of blood)
Blood urea increased
Haemoglobin decreased
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Hyperglycaemia (high blood sugar)
Blood creatinine increased

What are the common drug interactions of Tenormin and Afinitor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anaemia (lack of blood)
Neoplasm progression (growth of tumour)
Pulmonary oedema (fluid accumulation in the lungs)
Decreased appetite
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diverticulum intestinal haemorrhagic (a pouch that is attached to the first part of the small intestine with bleeding)
Dysgeusia (disorder of the sense of taste)
Eosinophil count increased
Malaise (a feeling of general discomfort or uneasiness)
Malignant neoplasm progression (cancer tumour came back)

40-49:

Stomatitis (inflammation of mucous membrane of mouth)
Rash
Interstitial lung disease
Abdominal pain
Decreased appetite
Epistaxis (bleed from the nose)
Exfoliative rash (scaly red generalized skin rash)
Fatigue (feeling of tiredness)
Herpes zoster
Lung cancer metastatic (lung cancer spreads to other parts)

50-59:

Decreased appetite
Dehydration (dryness resulting from the removal of water)
Herpes zoster

60+:

Pyrexia (fever)
Renal impairment (severely reduced kidney function)
Hyperglycaemia (high blood sugar)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Blood urea increased
Haemoglobin decreased
Nausea (feeling of having an urge to vomit)
Malaise (a feeling of general discomfort or uneasiness)
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Blood creatinine increased

What are the existing conditions these people have? *

Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 26 people, 53.06%
Renal Cell Carcinoma (a kidney cancer): 14 people, 28.57%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 8.16%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 8.16%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 6.12%
Breast Cancer: 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Tenormin and Afinitor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously